predictive-oncology.com - צמיחת מכירות משנה לשנה (TTM) POAI

Predictive Oncology is mitigating risks by implementing AI platforms and a biobank for drug discovery. This TTM annual revenue growth chart confirms the trend, where the current level is -47.70. Rising demand for computer modeling from biotech giants is expanding the market, while a cloud architecture ensures high business scalability with low operating expenses.

To protect capital, investors must filter out issuers with unstable operating cash flows. The diversification of the Predictive Oncology (POAI) client base through partnerships with pharma behemoths and AI platforms strengthens its financial foundation. Analyzing this 12-month YoY sales growth chart, the user can see the percentage change in TTM revenue compared to the previous year. This indicator visualizes the depth of drawdowns and the speed of revenue recovery. Positive price action confirms the scalability of the business model.